BioSpace News Archive

AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, was ranked 6th on the Philadelphia Business Journal’s 2019 “Soaring 76” list of fastest-growing companies in greater Philadelphia region as measured by revenue over a three-year period from 2017 through 2019.

Accent Therapeutics today announced that it has been named by Fierce Biotech as one of 2020’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry. Accent is a leader in the development of small molecule therapies that selectively inhibit RNA-modifying proteins (RMPs) that drive cancer. By targeting RMPs, the company is taking a novel appr

FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is pleased to announce it has entered into a manufacturing agreement with iBiologics to supply its proprietary allogeneic fibroblast ce

Aligos Therapeutics, Inc. (Aligos), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that the Company has received approval for a clinical trial application (CTA) for a first-in-human Phase 1a/b proof-of-concept clinical trial. Aligos may now commence study ALG-000184-201 (NCT04536337) to evaluate ALG-000184, a small mole

Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24. This press release features multimedia. View the full release here: https://www.businesswire.

The Society of Corporate Compliance and Ethics & Health Care Compliance Association (SCCE & HCCA) is pleased to announce the election of two new members to its Board of Directors, taking office on November 1, 2020, and the re-election of five existing board members to new terms.

Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries

Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer’s disease (AD), announces the closing of an over-subscribed Series R financing round. Cognoptix has undergone a complete revitalization over the past year. The company attracted the involvement of

Biocom, the association representing the life science industry of California, today announced the appointment of Stephanie Hsieh as the organization’s executive director for its Los Angeles office, effective immediately. “Steph is an accomplished biotech executive with deep industry knowledge t

Endeavors is pleased to announce the appointment of Traci Gomez as Chief Development Officer.